Life-threatening acute acalculous cholecystitis in a patient with renal cell carcinoma treated by sunitinib: A case report

Journal of Medical Case Reports

Volumn 6, Issue , 2012, Pages

  Nakano, Kazuhiko ^a   Suzuki, Kazumi ^a   Morita, Tatsuo ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIBIOTIC AGENT; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; GABEXATE MESILATE; LACTATE DEHYDROGENASE; SUNITINIB;

ABDOMINAL PAIN; ABDOMINAL SWELLING; ACALCULOUS CHOLECYSTITIS; ACUTE DISEASE; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PATIENT; CASE REPORT; CHOLECYSTOSTOMY; COMPUTER ASSISTED TOMOGRAPHY; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; JAPANESE; KIDNEY CARCINOMA; NECROSIS; NEPHRECTOMY; PRIORITY JOURNAL; THROMBOCYTOPENIA;

EID: 84862790817     PISSN: None     EISSN: 17521947     Source Type: Journal    
DOI: 10.1186/1752-1947-6-69     Document Type: Article

References (9)

1. Surgical resection of renal cell carcinoma after targeted therapy. Thomas AA, Rini BI, Stephenson AJ, Garcia JA, Fergany A, Krishnamurthi V, Novick AC, Gill IS, Klein EA, Zhou M, Campbell SC, J Urol 2009 182 881 886 10.1016/j.juro.2009.05.014 19616232
2. Emphysematous cholecystitis in a patient with gastrointestinal stromal tumor treated with sunitinib. de Lima Lopes G Jr, Rocha Lima CM, Pharmacotherapy 2007 27 775 777 10.1592/phco.27.5.775 17461715 (Pubitemid 46700972)
3. Acalculous cholecystitis in a patient with metastatic renal cell carcinoma treated with sunitinib. Gomez-Abuin G, Karam AA, Mezzadri NA, Bas CA, Clin Genitourin Cancer 2009 7 62 63 10.3816/CGC.2009.n.011 19213671
4. A method for estimating the probability of adverse drug reactions. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ, Clin Pharmacol Ther 1981 30 239 245 10.1038/clpt.1981.154 7249508 (Pubitemid 12149145)
5. Acute acalculous cholecystitis. Barie PS, Fischer E, J Am Coll Surg 1995 180 232 244 7850064
6. Molecular basis of hypertension side effects induced by sunitinib. Aparicio-Gallego G, Afonso-Afonso FJ, Leon-Mateos L, Firvida-Perez JL, Vazquez-Estevez S, Lazaro-Quintela M, Ramos-Vazquez M, Fernandez-Calvo O, Campos-Balea B, Anton-Aparicio LM, Anticancer Drugs 2011 22 1 8 10.1097/CAD.0b013e3283403806 20938340
7. Anti-angiogenic tyrosine kinase inhibitors: what is their mechanism of action? Gotink KJ, Verheul HM, Angiogenesis 2010 13 1 14 10.1007/s10456-009- 9160-6 20012482
8. Vascular complications of selected cancer therapies. Daher IN, Yeh ET, Nat Clin Pract Cardiovasc Med 2008 5 797 805 10.1038/ncpcardio1375 18852710
9. VEGF inhibition and renal thrombotic microangiopathy. Eremina V, Jefferson JA, Kowalewska J, Hochster H, Haas M, Weisstuch J, Richardson C, Kopp JB, Kabir MG, Backx PH, Gerber HP, Ferrara N, Barisoni L, Alpers CE, Quaggin SE, N Engl J Med 2008 358 1129 1136 10.1056/NEJMoa0707330 18337603 (Pubitemid 351398487)